Background: aMUPA mice carry as a transgene the cDNA encoding urokinase-type plasminogen activator, a member of the plasminogen/plasmin system that functions in fibrinolysis and extracellular proteolysis. These mice spontaneously consume less food when fed ad libitum and live longer compared with wild-type (WT) control mice. aMUPA mice are obesity resistant and they share many similarities with calorically restricted animals. However, extensive metabolic characterization of this unique transgenic model has never been performed. Method: Metabolism of aMUPA mice was analyzed by measuring hormone, lipid and glucose levels in the serum, as well as gene and protein expression levels in the liver, hypothalamus and brainstem. Results: aMUPA mice were found to be leaner than WT mice mainly because of reduced fat depots. Serum analyses showed that aMUPA mice have high levels of the anorexigenic hormones insulin and leptin, and low levels of the orexigenic hormone ghrelin. Analyses of brain neuropeptides showed that the transcript of the anorexigenic neuropeptide Pomc is highly expressed in the brainstem, whereas the expression of the orexigenic neuropeptides Npy, Orexin and Mch is blunted in the hypothalamus of aMUPA mice. In addition, adenosine monophosphate (AMP)-activated protein kinase (AMPK) levels were higher in the liver and lower in the hypothalamus, thus promoting simultaneously central reduction in appetite and peripheral loss of fat. The levels of SIRT1 were low in the liver, but high in the hypothalamus, a feature that aMUPA mice share with calorically restricted animals. Conclusion: Taken together, aMUPA mice exhibit a unique metabolic phenotype of low-calorie intake and high leptin levels, and could serve as a model for both spontaneous calorie restriction and resistance to obesity.
Introduction
The hypothalamus has a crucial role in determining energy homeostasis. 1 It is influenced by nutrients and hormones, such as leptin, insulin, ghrelin and adiponectin. Leptin, a satiety signal secreted from the adipose tissue, stimulates anorexigenic neurons within the hypothalamic arcuate nucleus to express pro-opiomelanocortin (POMC) and cocaineand amphetamine-regulated transcript (CART). POMC gives rise posttranslationally to a-melanocyte-stimulating hormone, which subsequently activates the melanocortin receptor in the paraventricular and lateral hypothalamus and results in decreased food intake and increased energy expenditure. 1 In parallel, leptin suppresses and ghrelin activates a distinct set of orexigenic neurons within the arcuate nucleus expressing neuropeptide Y (NPY) and agouti-related protein (AgRP). These peptides lead to the secretion of orexins and melanocyteconcentrating hormone (MCH) from the lateral hypothalamus and induce wakefulness and food-seeking behavior. Leptin and ghrelin also affect orexin-and MCH-expressing neurons directly. 2, 3 Thus, low levels of leptin and insulin during fasting or starvation and high levels of ghrelin and adiponectin activate orexigenic and inhibit anorexigenic neurons, leading to food-seeking behavior and increased food intake. 1 Leptin, ghrelin and insulin all affect adenosine monophosphate (AMP)-activated protein kinase (AMPK) considered as the cellular 'fuel gauge', switching off anabolic pathways and turning on adenosine triphosphate-producing pathways. 4 AMPK has a key role in both the liver and the hypothalamus. During fasting, AMPK activation in the liver leads to its phosphorylation, and, as a result, inactivation of acetyl CoA carboxylase (ACC), the rate-limiting enzyme in fatty acid synthesis. Consequently, the levels of malonyl CoA, the product of ACC catalysis, decrease leading to increased import of fatty acids into the mitochondrial matrix and their subsequent oxidation. In the hypothalamus, AMPK has a key role in whole body energy homeostasis. Activation of hypothalamic AMPK is mediated by ghrelin and adiponectin leading to an increase in orexigenic neuropeptides and stimulation of food intake, whereas inactivation of AMPK by glucose, insulin and leptin leads to the inhibition of food intake. [5] [6] [7] [8] Other key players in energy metabolism are SIRT1 and peroxisome-proliferator activator receptor-g (PPARg) coactivator 1a (PGC-1a). SIRT1 is a mammalian homolog of the yeast Sir2 protein, 9 which is a member of the aMUPA mice carry as a transgene the cDNA encoding urokinase-type plasminogen activator (uPA) fused to the enhancer-promoter region of the aÁ -crystallin gene. 18 uPA is an extracellular serine protease that has a role in fibrinolysis and tissue remodeling 19 and has been implicated in brain development and plasticity. [20] [21] [22] [23] [24] [25] aMUPA mice show transgenic expression in the ocular lens as expected from the promoter specificity, however, and also show ectopic expression specifically in the brain and developing teeth. 26, 27 aMUPA mice have been used as a model for caloric restriction (CR), as these mice spontaneously consume 20-30% less food when fed ad libitum and live longer (B20%) compared with wild-type (WT) control FVB/N mice. 28, 29 In addition, aMUPA mice are resistant to obesity and remain lean throughout their lifetime. 26, 30 aMUPA mice exhibit additional similarities with calorically restricted mice, such as reduced body weight and body temperature, reduced levels of serum insulin-like growth factor-1 or glucose, increased levels of mitochondrion-mediated apoptosis and reduced incidence of spontaneous and induced cancerous lesions. 26, 31, 32 The spontaneously reduced calorie intake seen in aMUPA mice indicates that these mice differ from WT mice and CR-treated animals in some aspects of energy metabolism. However, an extensive characterization of aMUPA mice metabolism has never been performed. Therefore, our aim was to characterize the metabolic state of aMUPA mice in the serum, liver, hypothalamus and brainstem. Our results show that aMUPA mice exhibit a satiated phenotype with increased leptin levels, a state distinct from that of WT mice and CR-treated animals. ) and blood, liver, hypothalamus and brainstem were collected at two time points, ZT8 (n ¼ 20 from each mouse type) and ZT16 (n ¼ 20 from each mouse type) (ZT0Fthe time when lights turn on). These time points were selected as the mid-rest and mid-activity phases, respectively. At the time of blood collection, blood glucose was measured using a digital glucometer (Optium Xceed, Abbott Laboratories, Alameda, CA, USA). Triglycerides, total cholesterol, high-density lipoprotein and low-density lipoprotein were analyzed using an enzymatic test according to the manufacturer's instructions (Roche, Basel, Switzerland). Tissues were immediately frozen in liquid nitrogen and stored at À80 1C for further analysis. The Institutional Animal Care and Use Committee (IACUC) of the Hebrew University and Hadassah Medical Center approved the study protocol for animal welfare. The Hebrew University is an AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) institute.
Materials and methods

Body fat composition
Fat percentage was measured in 8-month-old female WT and aMUPA mice (n ¼ 8 of each group) using double X-ray absorption (GE Lunar PIXImus, Madison, WI, USA), as described previously. 33 During body composition measurements, aMUPA and WT mice were anesthetized with isoflurane using an anesthetic machine (Ohmeda Medical, Laurel, MD, USA) with medical grade oxygen (2-3% vol). RNA extraction and quantitative real-time PCR For gene expression analyses, RNA was extracted from the hypothalamus, brainstem or liver using TRI Reagent (Sigma, Rehovot, Israel) according to the manufacturer's instructions. RNA quality was validated using spectrometry by calculating 260/280 nm and 260/230 nm ratios. Total RNA was DNase I treated using RQ1 DNase (Promega, Madison, WI, USA) for 2 h at 37 1C as previously described. 34 In all, 2 mg of DNase I-treated RNA was reverse transcribed using MMuLV reverse transcriptase (Promega) and random hexamers. Of the reaction, 1/20 was then subjected to quantitative real-time PCR using the primers spanning intron-exon boundaries and the ABI Prism 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Primers for Pomc, Npy, Orexin, Mch, Agrp, Ppara, Pparg and Pgc-1a were tested alongside the normalizing gene glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (Supplementary Table S1 ). Primers were designed with Primer express v.2 (Applied Biosystems) and validated by a standard curve and dissociation curve of the product. The fold change in target gene expression was calculated by the 2 ÀDDCt relative quantification method (Applied Biosystems). All genes showed the same trend in both aMUPA and WT mice. Some showed differences between ZT8 and ZT16 but with the same trend in both mouse types. Although differences between ZT8 and ZT16 in both aMUPA mice and WT mice could suggest a circadian pattern, we could not rely on two time points to determine circadian rhythmicity. ZT8 and ZT16 for each gene were averaged for a better assessment of transcript levels.
Western blot analysis
Tissue samples were homogenized in lysis buffer (20 mM Tris, 145 mM NaCl, 5% glycerol, 1% Triton, 100 mM phenylmethylsulfonyl fluoride, 50 mM NaF, 1 mM sodium orthovanadate, 10 mg ml À1 leupeptin, 10 mg ml À1 aprotinin, 0.8 mg ml À1 trypsin inhibitors), as described previously. 35 Samples were run on an SDS-polyacrylamide gel (10% for AMPK and SIRT1, 7.5% for ACC) and subsequently proteins were transferred into a nitrocellulose membrane. Blots were incubated with mouse anti-AMPK/pAMPK/ACC/pACC (Cell Signaling Technology Inc., Danvers, MA, USA) or anti-SIRT1 (Millipore, Billerica, MA, USA) antibodies and after several washes with anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (Cell Signaling Technology Inc.). b-Actin was used as the loading control. The immune reaction was detected by enhanced chemiluminescence. Bands were quantified by scanning and densitometry and expressed as arbitrary units. For a better assessment of protein levels, ZT8 and ZT16 were averaged.
Statistics
Student's t-test was used for comparison between mouse strains. For all analyses, the significance level was set at Po0.05.
Results
Body composition of aMUPA and WT mice Analysis of body composition showed that aMUPA mice weigh less than WT mice, their genetic background (aMUPA, 25.0±1 g; WT, 31.8±4.7 g; Po0.01) (Figure 1 ). In addition, the fat percentage of aMUPA mice was significantly lower than that of WT mice (aMUPA, 21.7 ± 3.0%; WT, 34.6 ± 3.1%; Po0.01) (Figure 1 ). The 5.84 g difference in fat mass (aMUPA, 5.47±0.8 g; WT, 11.3±1.51g; Po0.01) (Figure 1 ) explained 85.8% of the difference in body weight. Taken together, these results show that aMUPA mice are leaner than WT mice mainly because of reduced fat depots.
Levels of glucose, lipids and hormones in the serum of aMUPA and WT mice To characterize the metabolic status of aMUPA mice, we first measured glucose and lipid levels in the serum and compared them with those of WT mice. To better evaluate the levels of these parameters, we measured them at two time points, mid-rest phase (ZT8) and mid-activity phase (ZT16). Glucose and triglyceride levels were not significantly different in the two strains after a 12-h fasting period (Table 1) . However, cholesterol levels, total cholesterol, highdensity lipoprotein and low-density lipoprotein were significantly higher (Po0.05) in aMUPA mice than in WT mice (Table 1) . Although cholesterol levels were slightly higher in aMUPA mice, they were within the normal range. We next measured the concentrations of several hormones that regulate feeding, that is, insulin, glucagon, leptin, ghrelin, adiponectin, PYY 3À36 , cholecystokinin and corticosterone. Glucagon, adiponectin, cholecystokinin and corticosterone did not show significant difference between aMUPA and WT mice (Table 1 ). In contrast, PYY 3À36 exhibited high Fat weight was determined using double X-ray absorption (DEXA). *Po0.01, t-test between lines of mice.
Reduced fat tissue and high leptin in aMUPA mice O Froy et al levels in WT mice than in aMUPA mice (Po0.05) (Figure 2) , with expected higher levels during the feeding phase (data not shown). Insulin levels were B3.5-fold higher in aMUPA mice than in WT mice (Po0.05) (Figure 2) . Similarly, leptin levels were B4.5-fold higher in aMUPA mice than in WT mice (Po0.05) (Figure 2) . In aMUPA mice, the levels of leptin inversely correlated with those of body fat (1739.2pg ml À1 per g fat) compared with WT mice (274.9 pg ml À1 per g fat),
yielding a 6.3-fold ratio difference (Po0.001, coefficient correlation of 0.73 for WT mice and 0.86 for aMUPA mice).
In correlation with leptin and insulin, ghrelin exhibited lower levels in aMUPA mice than in WT mice (Po0.05) ( Figure 2 ). As expected, in both strains, ghrelin showed a daily variation being high during the rest period and low during the feeding period (data not shown). Taken together, these results show that aMUPA mice have high levels of the satiety hormones insulin and leptin, and low levels of the hunger hormone ghrelin.
Levels of mRNA expression of PPARa, PPARg and PGC-1a in the liver As fat depots are the main difference between aMUPA and WT mice, we determined the expression level of several transcription factors involved in lipid metabolism. In aMUPA mice, Pgc-1a mRNA levels were decreased, whereas those of Pparg were significantly higher than in WT mice (Po0.05) (Figure 3 ). Ppara was not significantly different between aMUPA and WT mice (Figure 3) .
Levels of brain neuropeptides in aMUPA and WT mice We next examined the mRNA level of neuropeptides involved in feeding behavior in the brainstem and hypothalamus, the two regions in the brain involved in energy homeostasis. We focused on the anorexigenic neuropeptide POMC and the orexigenic neuropeptides NPY, orexin, MCH and AgRP. In the hypothalamus, mRNA expression levels of Pomc and Agrp did not differ between the two strains ( Figure 4) . However, expression levels of the orexigenic neuropeptides Npy, Orexin and Mch were significantly reduced in the hypothalamus of aMUPA mice by approximately fivefold (Po0.05) (Figure 4 ). In the brainstem, Pomc exhibited B3-fold higher level of expression in aMUPA mice (Po0.05) ( Figure 4 ). As expected, 36 Agrp expression could not be detected in the brainstem (Figure 4 ). Taken together, these results show that the anorexigenic neuropeptide Pomc is highly expressed in the brainstem, whereas the expression of the orexigenic neuropeptides Npy, Orexin and Mch is Reduced fat tissue and high leptin in aMUPA mice O Froy et al blunted in the hypothalamus of aMUPA mice, leading to overall satiety.
Levels of AMPK, ACC and SIRT1 in aMUPA and WT mice As insulin, leptin and ghrelin affect the activation of AMPK, the energy 'gauge' in the cell, which has a critical role in energy homeostasis, we evaluated its levels in the liver, hypothalamus and brainstem. Ampk mRNA was significantly (Po0.05) lower in the liver, brainstem and hypothalamus in aMUPA mice than in WT mice ( Figure 5) . At the protein level, AMPK levels were lower in aMUPA mice in the liver, but its phosphorylated active form (pAMPK) levels were significantly higher (Po0.05) ( Figure 5 ). In the hypothalamus, total AMPK protein levels were significantly higher in aMUPA mice than in WT mice (Po0.05) ( Figure 5 ). However, hypothalamic pAMPK levels were significantly lower in aMUPA mice compared with those of WT mice (Po0.05) ( Figure 5 ). In the brainstem, neither average AMPK nor pAMPK levels differed between the mouse strains ( Figure 5 ). As AMPK phosphorylates and, hence, inactivates ACC, we determined total ACC protein levels and its phosphorylated fraction. In both the liver and the hypothalamus, we found significantly higher levels of ACC and pACC in aMUPA mice compared with WT mice (Po0.05) ( Figure 6 ). As aMUPA mice live longer and share similar features with animals under CR, 26 we evaluated SIRT1 levels, a key metabolic regulator that has been implicated in the in vivo response to CR 37 and CR-mediated life span extension. 38 In the liver, levels of the SIRT1 protein were significantly lower in aMUPA mice than in WT mice (Po0.05) ( Figure 7 ). In contrast, hypothalamic SIRT1 protein levels were significantly higher (Po0.05) in aMUPA mice than in WT mice ( Figure 7 ).
Discussion
The results of this study indicate that aMUPA mice have a unique metabolic phenotype of reduced calorie intake accompanied with satiety. Accordingly, aMUPA mice have significantly reduced fat depots in their body compared with their genetic background WT mice. Hormonal analyses reflect quite clearly that aMUPA mice exhibit a satiated state compared with WT mice, as they have high serum levels of leptin and insulin, which induce satiety, and low levels of ghrelin, a hunger-inducing peptide. 8, 39 These results are compelling, as the animals were fasted 12 h before all analyses and they have less leptin-producing fat tissue. Ghrelin has been shown in some studies to have an inhibitory effect on insulin secretion, 40 explaining, at least in part, the higher levels of insulin in aMUPA mice. The levels of PYY 3À36 , which is secreted in the small intestine after the meal, are known to correlate with the amount of digested calories and inhibit food intake for several hours. 41 As aMUPA mice consume fewer calories than do WT mice, the low levels found in aMUPA are expected. Reduced food intake, which occurred unexpectedly in aMUPA mice, was detected in two transgenic lines 26, 31 thus pointing to uPA, the product of transgenic expression, as the primary causative factor. The transgenic effect is likely to be developmental, similarly to the impressive remodeling effect recently detected in aMUPA developing incisor teeth. 27 More specifically, the two transgenic lines show ectopic expression of uPA in the trigeminal nucleus of the brain stem, a region devoid of uPA expression in the WT brain. 26 Thus, although this region has not been associated so far with food intake, it Relative mPpar mRNA levels Figure 3 Pgc-1a, Pparg and Ppara mRNA expression levels in the liver. Liver tissue was collected from WT or aMUPA mice and total RNA was extracted. Real-time PCR analyses were performed to determine mRNA level of Pgc-1a (a), Pparg (b) and Ppara (c). Levels are mean ± s.e.m., n ¼ 16 for each strain, *Po0.05.
Reduced Reduced fat tissue and high leptin in aMUPA mice O Froy et al system resulting in oversecretion of leptin in aMUPA mice notwithstanding low fat body levels. The satiety exhibited in aMUPA mice, as detected in this study, the capacity of aMUPA mice to accomplish their daily dose within a 3-h period under restricted feeding 43 and the finding that aMUPA mice ate less even when fed pulverized food 26 all reiterate the fact that the superficial enamel alterations previously reported in aMUPA incisors 27 do not affect feeding in these transgenic mice. The higher levels of leptin and insulin and lower levels of ghrelin in aMUPA could be the key to their altered energy homeostasis. High levels of leptin and insulin lead to inhibition of NPY/AgRP neurons and decreased hypothalamic AMPK activation, thus, leading to overall satiety. 4, 44 In contrast, high ghrelin levels lead to activation of NPY/AgRP neurons and AMPK, thus leading to increased appetite. 39, 44 Indeed, pAMPK levels, the activated form of AMPK, were lower in the hypothalamus in aMUPA mice. In the lateral hypothalamus, inhibition of NPY/AgRP by leptin also leads to decreased expression of orexin and MCH, peptides which induce wakefulness and food-seeking behavior. 45 Indeed, in aMUPA mice, the levels of these orexigenic neuropeptides were lower in the hypothalamus compared with WT mice. These findings were supported by increased levels of Pomc expression in their brainstem, as POMC neurons in the nucleus tractus solitarius have been shown to relay satiety signals from the periphery to the hypothalamus. 46 In parallel, in the liver, leptin and insulin lead to AMPK activation and ghrelin to AMPK suppression. 39 Activation of AMPK in the liver leads to inhibition of fatty acid synthesis and increased fatty acid oxidation. 4 Indeed, pAMPK levels were higher in the liver in aMUPA mice. The opposite effects on AMPK in aMUPA mice, inhibition in the hypothalamus alongside activation in the liver, promote simultaneously central reduction in appetite and peripheral loss of fat. It is also noted that although pAMPK levels were lower in the hypothalamus, the levels of pACC were higher in aMUPA mice. These results may indicate that ACC could be phosphorylated by other kinases or that its phosphatase activities are reduced, at least in this brain area.
As PGC-1a is activated under fasting in the liver, 12 the reduction in its mRNA expression levels supports the satiated state of aMUPA. In contrast, Pparg expression levels were higher than those of WT mice. As PPARg is involved in fatty acid import into the cell, 16 the increase in Pparg expression could stem from the high fatty acid oxidation in the liver, as a result of AMPK activation. As PPARg requires PGC-1a as a transcription coactivator, and PGC-1a remained low, this could explain why lipogenic and adipogenic pathways in aMUPA were not activated. The low levels of the SIRT1 protein correlate with the low Pgc-1a and high Pparg expression levels, as SIRT1 represses PPARg and activates PGC-1a. 47 aMUPA mice share some similarities with those of Lou/C, both obesity-resistant long-lived rodents. However, there are some fundamental differences in Lou/C rats compared with aMUPA mice, such as increased levels of PGC-1a and SIRT1 in the liver, increased levels of ghrelin and reduced levels of leptin and insulin in the serum, although with some improved sensitivity for the latter two hormones. 48, 49 Overall, it seems that aMUPA mice are metabolically different from Lou/C rats. Although aMUPA mice exhibit reduced calorie intake and body fat, they show remarkable differences in energy metabolism compared with CR-treated animals. In particular, calorically restricted animals exhibit high levels of ghrelin and low levels of leptin 50 and insulin. 51 In addition, CR-treated mice exhibit high expression levels of PGC-1a and no change in Pparg levels in the liver. 50, 52 These findings are in sharp contrast with those found in aMUPA mice. Despite these differences, both calorically restricted animals 51 and aMUPA mice 26 benefit from the reduced calories as both show improved health and extended life span. Interestingly, aMUPA mice showed low SIRT1 expression in the liver similar to CR-treated animals 53 and high levels in the hypothalamus similar to starved animals. 54 Results obtained with SIRT1-null mice have recently suggested that this enzyme is required for in vivo response to CR. 37 It seems that SIRT1 levels could be elevated in the hypothalamus through AMPK activation in calorically restricted mice, 55 and through leptin signaling 54 in aMUPA mice.
Recent studies have shown that SIRT1 interacts directly with CLOCK and deacetylates BMAL1 and PER2, proteins of the core mechanism of the circadian clock. 56, 57 In addition, SIRT1 
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Figure 7 SIRT1 protein levels in the liver and hypothalamus. Tissues were collected from WT and aMUPA mice. SIRT1 protein levels were determined by western blots. Levels are mean±s.e.m., n ¼ 16 for each strain, *Po0.05.
Reduced fat tissue and high leptin in aMUPA mice O Froy et al mRNA was found to be abundant in the suprachiasmatic nucleus, 54 a hypothalamic area comprising the central circadian clock. The suprachiasmatic nucleus expresses leptin receptors 58 and could respond to direct exposure to leptin. 59, 60 Therefore, we suggest that in aMUPA mice, the high leptin levels could facilitate SIRT1 activation in the suprachiasmatic nucleus, which, in turn, leads to robust circadian rhythms, as we have shown. 30, 34 As robust circadian rhythms can extend the life span and CR is capable of entraining the suprachiasmatic nucleus clock, 30 the increased hypothalamic SIRT1 levels in aMUPA mice could be a key mediator through which their circadian clock is synchronized, thus improving health and extending longevity. In summary, unlike CR-treated animals and Lou/C rats, aMUPA mice show an unusual combination of low-calorie intake and metabolism of satiated animals with high levels of leptin. Increased leptin levels lead, most likely, to the reduced hypothalamic expression of orexigenic neuropeptides, which, in turn, reduces appetite. Although the mechanism by which aMUPA mice exhibit such features remains to be elucidated, aMUPA mice could be a model for both spontaneous calorie restriction and resistance to obesity.
